Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Hannah Brendan
CHIEF BUSINESS OFFICER AND COO at Quince Therapeutics. Filing since 8 Aug 2023.
CIK 0001929422
Company
Date
Role
Action
Shares
Amount
Of holding
QNCX
Quince Therapeutics, Inc.
21 Aug 2024
CHIEF BUSINESS OFFICER AND COO
Bought
30,845
$19.34K
11.6%
QNCX
Quince Therapeutics, Inc.
20 Aug 2024
CHIEF BUSINESS OFFICER AND COO
Bought
5,924
$3.58K
2.3%
QNCX
Quince Therapeutics, Inc.
19 Aug 2024
CHIEF BUSINESS OFFICER AND COO
Bought
2,155
$1.25K
0.8%
QNCX
Quince Therapeutics, Inc.
8 Aug 2023
Chief Business Officer
Bought
71,762
$87.55K
55.3%
4 decisions on file.
